NEW YORK, Sept. 13, 2017 /PRNewswire/ -- Young America
Capital (YAC) is pleased to announce that it has successfully
assisted Pleuratech in entering an exclusive worldwide
license agreement with Merit Medical for Pleuratech's main product,
a novel surgical device ensuring safe and accurate placement of
drains in the pleural cavity.
Headquartered in Århus, Denmark, Pleuratech and its two founders,
Niels Katballe and Peter Heydorn
have developed the KatGuide, an innovate surgical device. The
uniquely shaped, patented and clinically tested KatGuide can guide
the chest tube to the part of the pleural cavity that needs
drainage. With more successful surgeries and fewer misplaced drains
as a result.
Merit Medical Systems (NASDAQ: MMSI) is a leading
worldwide manufacturer of medical devices used primarily in
cardiology, radiology and endoscopy. Merit employs approximately
4,500 people worldwide. In 2016, the company had a turnover of over
$600 Million.
The multimillion dollar license agreement means that the
patented product is a giant step closer to becoming the industry
standard for pleural drainage procedures.
"As a leading manufacturer and marketer of proprietary
disposable medical devices, Merit Medical Systems, Inc. is excited
to add the KatGuide to our current portfolio of products.
This innovative medical device delivers to clinicians a unique tool
proven to improve the efficacy of chest tube placement. The
resulting benefits will help ensure conditions for optimal drainage
and, therefore, improve patient care," says Fred P. Lampropoulos, Merit's Chairman and
CEO.
Young America Capital works with international early stage
companies who seek investors or market access in the US. YAC's
ability to assist Scandinavian companies is emphasized by having
New York based Dane, Jakob Bergendorff, on our team to compliment a
group of 35+ Investment Bankers focused on the lower middle market.
Please contact us if you would like to learn more about our team
and services.
About Young America Capital, LLC
Founded in 2000, Young America Capital is a New York-based
FINRA/SEC/MSRB licensed independent investment banking and advisory
firm which provides capital raising, M&A advisory and fund
marketing services for companies and alternative investment fund
managers. The company is comprised of a diverse group of
senior investment banking professionals with particularly deep
sector experience in Consumer & Retail, Energy &
Clean-Tech, Technology, Media and Telecom, Healthcare & Life
Sciences; Maritime, Infrastructure & Logistics, Financial
Services & Fin-Tech, Real Estate, and Latin
America. www.yacapital.com
Media Contact:
Peter Formanek
914-777-0100
peter@yacapital.com
View original
content:http://www.prnewswire.com/news-releases/young-america-capital-successfully-assisted-pleuratech-in-entering-into-an-exclusive-worldwide-license-agreement-with-merit-medical-300519294.html
SOURCE Young America Capital